{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:17Z","timestamp":1787020817714,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","award":["R198-A9014"],"award-info":[{"award-number":["R198-A9014"]}],"id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013826","name":"Candys Foundation","doi-asserted-by":"publisher","award":["No grant number"],"award-info":[{"award-number":["No grant number"]}],"id":[{"id":"10.13039\/501100013826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Royal Library, Copenhagen University Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A predominant side effect of radiotherapy for head and neck cancer is salivary gland hypofunction and xerostomia leading to debilitating oral disorders and impaired quality of life (QoL). Intraglandular mesenchymal stem cell therapy has shown promising results as a treatment for xerostomia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a randomised, double-blinded, placebo-controlled, parallel-group, prospective, single-centre trial investigating the safety, tolerability, and effectiveness of allogeneic stem cells as a treatment for radiation-induced hyposalivation and xerostomia for previous head and neck cancer patients.<\/jats:p>\n                    <jats:p>\n                      We will include a total of 120 patients who previously have been treated with radiotherapy for a head and neck cancer in Denmark. Participants will be randomly assigned using block randomisation to one of two parallel groups in a 1:1 ratio to receive ultrasound-guided injection of allogeneic adipose-derived mesenchymal stem cell (ASC) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200960) or placebo (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200960) into the submandibular glands. Placebo will consist of CryoStor10 (BiolifeSolutions), the freeze media for ASCs containing 10% dimethyl sulfoxide (DMSO). The primary endpoint is change in unstimulated whole saliva flow rate. The secondary endpoints are change in stimulated whole saliva flow rate, QoL, and composition of saliva. Further secondary endpoints are safety and immune response (human leukocyte antigen\u00a0(HLA) response) to the stem cells will be assessed. Patients are evaluated at baseline (before treatment), after 4\u00a0months, and after 12\u00a0months. All study personnel, except study personnel thawing and preparing the treatment for injection, and participants will be blinded to group assignment. Unblinded study personnel will not participate in the outcome assessment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The trials will investigate the efficacy and safety of ASC injection to the submandibular gland as a potential new treatment for post-radiation xerostomia. We hope the results will pave the way for a clinically relevant treatment to ameliorate patients with xerostomia, a severely hampering condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The study is approved by the Danish Data Protection Agency (protocol number P-2020-1164), the National Ethics Committee protocol number: (Protocol number: 1802872), and the Danish Medical Agency (2018-000348-24). The protocol was registered at the ClinicalTrials.gov database (NCT04776538).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07594-5","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T09:03:31Z","timestamp":1693559011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effectiveness and safety of mesenchymal stem\/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0336-5411","authenticated-orcid":false,"given":"Kathrine Kronberg","family":"Jakobsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda-Louise Fenger","family":"Carlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gr\u00f8nh\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Todsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Melchiors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasja","family":"Paaske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Kathrine \u00d8stergaard","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kastrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Ekblond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Haack-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Maare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe","family":"Friborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Duch","family":"Lynggard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"von Buchwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"7594_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejca.2017.05.026","volume":"82","author":"AA Hussein","year":"2017","unstructured":"Hussein AA, Helder MN, de Visscher JG, Leemans CR, Braakhuis BJ, de Vet HCW, et al. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review. Eur J Cancer. 2017;82:115\u201327.","journal-title":"Eur J Cancer"},{"key":"7594_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejca.2016.10.015","volume":"70","author":"A-LF Carlander","year":"2017","unstructured":"Carlander A-LF, Gr\u00f8nh\u00f8j Larsen C, Jensen DH, Garn\u00e6s E, Kiss K, Andersen L, et al. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: a Danish population-based study from 2011 to 2014. Eur J Cancer. 2017;70:75\u201382.","journal-title":"Eur J Cancer"},{"key":"7594_CR3","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/0284186X.2018.1438657","volume":"57","author":"KK Jakobsen","year":"2018","unstructured":"Jakobsen KK, Gr\u00f8nh\u00f8j C, Jensen DH, Karnov KKS, Agander TK, Specht L, et al. Increasing incidence and survival of head and neck cancers in Denmark: a nation-wide study from 1980 to 2014. Acta Oncol (Madr). 2018;57:1143\u201351.","journal-title":"Acta Oncol (Madr)"},{"key":"7594_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.radonc.2015.04.021","volume":"116","author":"JM Borras","year":"2015","unstructured":"Borras JM, Barton M, Grau C, Corral J, Verhoeven R, Lemmens V, et al. The impact of cancer incidence and stage on optimal utilization of radiotherapy: methodology of a population based analysis by the ESTRO-HERO project. Radiother Oncol. 2015;116:45\u201350. Elsevier Ireland Ltd.","journal-title":"Radiother Oncol"},{"key":"7594_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejca.2017.03.006","volume":"78","author":"S H\u00f8xbroe Michaelsen","year":"2017","unstructured":"H\u00f8xbroe Michaelsen S, Gr\u00f8nh\u00f8j C, H\u00f8xbroe Michaelsen J, Friborg J, von Buchwald C. Quality of life in survivors of oropharyngeal cancer: a systematic review and meta-analysis of 1366 patients. Eur J Cancer. 2017;78:91\u2013102. Elsevier Ltd.","journal-title":"Eur J Cancer"},{"key":"7594_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/154411130301400306","volume":"14","author":"A Vissink","year":"2003","unstructured":"Vissink A, Burlage FR, Spijkervet FKL, Jansma J, Coppes RP. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14:213\u201325.","journal-title":"Crit Rev Oral Biol Med"},{"key":"7594_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/02841869409083923","volume":"33","author":"AB Jensen","year":"1994","unstructured":"Jensen AB, Hansen O, J\u00f8rgensen K, Bastholt L. Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol. 1994;33:487\u201391.","journal-title":"Acta Oncol"},{"key":"7594_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3109\/00016357.2015.1099730","volume":"74","author":"P Lopez-Jornet","year":"2016","unstructured":"Lopez-Jornet P, Lucero Berdugo M, Fernandez-Pujante A, Castillo FC, Zamora LC, Pons-Fuster A, et al. Sleep quality in patients with xerostomia: a prospective and randomized case-control study. Acta Odontol Scand. 2016;74:224\u20138. Taylor and Francis Ltd.","journal-title":"Acta Odontol Scand"},{"key":"7594_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/154411130301400305","volume":"14","author":"A Vissink","year":"2003","unstructured":"Vissink A, Jansma J, Spijkervet FKL, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14:199\u2013212.","journal-title":"Crit Rev Oral Biol Med"},{"key":"7594_CR10","first-page":"207","volume":"11","author":"S Beier","year":"2002","unstructured":"Beier S, Anne J, Pedersen M, Reibel J, Nauntofte B. Xerostomia and hypofunction of the salivary glands in cancer therapy. Cancer Support Care Cancer. 2002;11:207\u201325.","journal-title":"Cancer Support Care Cancer"},{"key":"7594_CR11","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00520-010-0837-6","volume":"18","author":"SB Jensen","year":"2010","unstructured":"Jensen SB, Pedersen AML, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer. 2010;18:1061\u201379.","journal-title":"Support Care Cancer"},{"key":"7594_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.oooo.2013.11.496","volume":"117","author":"DH Jensen","year":"2014","unstructured":"Jensen DH, Oliveri RS, TrojahnK\u00f8lle S-F, Fischer-Nielsen A, Specht L, Bardow A, et al. Mesenchymal stem cell therapy for salivary gland dysfunction and\u00a0xerostomia: a systematic review of preclinical studies. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:335\u2013342.e1. Elsevier Inc.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"7594_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-017-1856-0","volume":"18","author":"C Gr\u00f8nh\u00f8j","year":"2017","unstructured":"Gr\u00f8nh\u00f8j C, Jensen DH, Glovinski PV, Jensen SB, Bardow A, Oliveri RS, et al. First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): Study protocol for a randomized controlled trial. Trials. 2017;18:1\u201310.","journal-title":"Trials"},{"key":"7594_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ijrobp.2018.02.034","volume":"101","author":"C Gr\u00f8nh\u00f8j","year":"2018","unstructured":"Gr\u00f8nh\u00f8j C, Jensen DH, Vester-Glowinski P, Jensen SB, Bardow A, Oliveri RS, et al. Safety and efficacy of mesenchymal stem cells for radiation-induced xerostomia: a randomized, placebo-controlled phase 1\/2 trial (MESRIX). Int J Radiat Oncol Biol Phys. 2018;101:581\u201392.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7594_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/stcltm\/szac011","volume":"11","author":"CD Lynggaard","year":"2022","unstructured":"Lynggaard CD, Gr\u00f8nh\u00f8j C, Christensen R, Fischer-Nielsen A, Melchiors J, Specht L, et al. Intraglandular off-the-shelf allogeneic mesenchymal stem cell treatment in patients with radiation-induced xerostomia: a safety study (MESRIX-II). Stem Cells Transl Med. 2022;11:478\u201389.","journal-title":"Stem Cells Transl Med"},{"key":"7594_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200\u20137. American College of Physicians.","journal-title":"Ann Intern Med"},{"key":"7594_CR17","unstructured":"Sundhedsstyrelsen [Danish Health Authority]. Prevention package alcohol [Forebyggelsespakke Alkohol]. 2018. Available from: https:\/\/www.sst.dk\/da\/udgivelser\/2018\/forebyggelsespakke-alkohol."},{"key":"7594_CR18","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1002\/sctm.17-0040","volume":"6","author":"J Kastrup","year":"2017","unstructured":"Kastrup J, Haack-S\u00f8rensen M, Juhl M, Harary S\u00f8ndergaard R, Follin B, Drozd Lund L, et al. Cryopreserved off-the-shelf allogeneic adipose-derived stromal cells for therapy in patients with ischemic heart disease and heart failure\u2014a safety study. Stem Cells Transl Med. 2017;6:1963\u201371.","journal-title":"Stem Cells Transl Med"},{"key":"7594_CR19","unstructured":"National Ethics Committee. The rights of participants in a health science research project [Fors\u00f8gspersoners rettigheder i et sundhedsvidenskabeligt forskningsprojekt]. 2014. Available from: https:\/\/nationaltcenterforetik.dk\/ansoegerguide\/ansoegninger-til-nvk-og-rvk\/dine-rettigheder-som-forsoegsperson-nvk-og-rvk."},{"key":"7594_CR20","unstructured":"National Ethics Committee. Before deciding [F\u00f8r du beslutter dig]. 2014. Available from: https:\/\/nationaltcenterforetik.dk\/ansoegerguide\/ansoegninger-til-nvk-og-rvk\/dine-rettigheder-som-forsoegsperson-nvk-og-rvk."},{"key":"7594_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2008.04.032","volume":"269","author":"L Qiao","year":"2008","unstructured":"Qiao L, Xu Z-L, Zhao T-J, Ye L-H, Zhang X-D. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett. 2008;269:67\u201377.","journal-title":"Cancer Lett"},{"key":"7594_CR22","doi-asserted-by":"publisher","first-page":"e6278","DOI":"10.1371\/journal.pone.0006278","volume":"4","author":"B Cousin","year":"2009","unstructured":"Cousin B, Ravet E, Poglio S, De Toni F, Bertuzzi ML, Lulka H, et al. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. Vitr Vivo PLoS One. 2009;4:e6278.","journal-title":"Vitr Vivo PLoS One"},{"key":"7594_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.leu.2404489","volume":"21","author":"R Ramasamy","year":"2007","unstructured":"Ramasamy R, Lam E-F, Soeiro I, Tisato V, Bonnet D, Dazzi F. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia. 2007;21:304\u201310.","journal-title":"Leukemia"},{"key":"7594_CR24","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1111\/j.1349-7006.2010.01731.x","volume":"101","author":"Z-Y Bian","year":"2010","unstructured":"Bian Z-Y, Fan Q-M, Li G, Xu W-T, Tang T-T. Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2. Cancer Sci. 2010;101:2554\u201360. Blackwell Publishing Ltd.","journal-title":"Cancer Sci"},{"key":"7594_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1476-4598-9-129","volume":"9","author":"L Kucerova","year":"2010","unstructured":"Kucerova L, Matuskova M, Hlubinova K, Altanerova V, Altaner C. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer. 2010;9:129.","journal-title":"Mol Cancer"},{"key":"7594_CR26","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jcyt.2013.01.217","volume":"15","author":"SF TrojahnK\u00f8lle","year":"2013","unstructured":"TrojahnK\u00f8lle SF, Oliveri RS, Glovinski PV, Kirchhoff M, Mathiasen AB, Elberg JJ, et al. Pooled human platelet lysate versus fetal bovine serum-investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissue-derived stem cells intended for clinical use. Cytotherapy. 2013;15:1086\u201397. Elsevier Inc.","journal-title":"Cytotherapy"},{"key":"7594_CR27","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3109\/14653249.2010.507330","volume":"12","author":"DJ Prockop","year":"2010","unstructured":"Prockop DJ, Brenner M, Fibbe WE, Horwitz E, Le Blanc K, Phinney DG, et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy. 2010;12:576\u20138.","journal-title":"Cytotherapy"},{"key":"7594_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0140-6736(13)61410-5","volume":"382","author":"S-FT K\u00f8lle","year":"2013","unstructured":"K\u00f8lle S-FT, Fischer-Nielsen A, Mathiasen AB, Elberg JJ, Oliveri RS, Glovinski PV, et al. Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. Lancet. 2013;382:1113\u201320.","journal-title":"Lancet"},{"key":"7594_CR29","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/j.0022-0337.2001.65.9.tb03439.x","volume":"65","author":"RK Simmons","year":"2001","unstructured":"Simmons RK, Baum BJ. Transferring genes to salivary glands. J Dent Educ. 2001;65:907\u201310.","journal-title":"J Dent Educ"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07594-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07594-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07594-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T19:29:23Z","timestamp":1700335763000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07594-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7594"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07594-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"24 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors C.D.L., C.G., and C.V.B. declare the following competing interests: Rigshospitalet and the University of Copenhagen have a pending patent application entitled \u201cStem cell therapy for salivary gland dysfunction\u201d published as WO 2020\/165405 A1, with K.K.J, C.D.L., C.G., and C.V.B. as the inventors. The authors A.E., M.H.S. and J.K. declare the following competing interests: A.E., M.H.S. and J.K. are inventors of the patent \u201cStem cell therapy based on adipose-derived stem cells\u201d (Publication WO 2017-068140). All authors met the ICMJE authorship criteria. No honoraria or payments were made for authorship. The remaining authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"567"}}